Coexpression	O
of	O
vascular	O
endothelial	O
growth	O
factor	O
and	O
p53	O
protein	O
in	O
squamous	B-Cancer
cell	I-Cancer
carcinoma	I-Cancer
of	O
the	O
esophagus	B-Organ
.	O

OBJECTIVE	O
:	O
p53	O
plays	O
a	O
role	O
in	O
tumor	B-Cancer
angiogenesis	O
,	O
and	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
plays	O
a	O
key	O
role	O
in	O
tumor	B-Cancer
angiogenesis	O
.	O

The	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
clarify	O
how	O
expression	O
of	O
p53	O
protein	O
participates	O
in	O
angiogenesis	O
,	O
and	O
whether	O
the	O
coexpression	O
of	O
VEGF	O
and	O
p53	O
protein	O
has	O
a	O
significance	O
for	O
angiogenesis	O
and	O
the	O
clinicopathological	O
features	O
in	O
esophageal	B-Cancer
squamous	I-Cancer
cell	I-Cancer
carcinoma	I-Cancer
(	O
SCC	B-Cancer
)	O
.	O

METHODS	O
:	O
Tissues	B-Tissue
samples	I-Tissue
were	O
taken	O
from	O
60	O
patients	O
with	O
esophageal	B-Cancer
SCC	I-Cancer
after	O
surgery	O
.	O

The	O
expression	O
of	O
VEGF	O
and	O
p53	O
protein	O
in	O
these	O
SCC	B-Cancer
was	O
examined	O
immunohistochemically	O
.	O

Microvessel	B-Tissue
density	O
(	O
MVD	O
)	O
was	O
determined	O
by	O
counting	O
microvessels	B-Tissue
in	O
tumor	B-Cancer
sections	I-Cancer
stained	O
for	O
Factor	O
VIII	O
-	O
related	O
antigen	O
.	O

Ki	O
-	O
67	O
labeling	O
index	O
(	O
LI	O
)	O
was	O
calculated	O
,	O
based	O
on	O
Ki	O
-	O
67	O
antigen	O
immunostaining	O
,	O
as	O
a	O
proliferative	O
marker	O
.	O

Apoptotic	O
index	O
(	O
AI	O
)	O
was	O
calculated	O
,	O
based	O
on	O
the	O
terminal	O
deoxynucleotidyl	O
transferase	O
-	O
mediated	O
deoxyuridine	O
triphosphate	O
biotin	O
nick	O
end	O
labeling	O
,	O
to	O
evaluate	O
apoptosis	O
.	O

RESULTS	O
:	O
VEGF	O
expression	O
was	O
observed	O
in	O
58	O
.	O
3	O
%	O
,	O
and	O
p53	O
protein	O
expression	O
was	O
observed	O
in	O
61	O
.	O
7	O
%	O
of	O
the	O
60	O
patients	O
.	O

VEGF	O
and	O
p53	O
protein	O
were	O
significantly	O
coexpressed	O
in	O
26	O
(	O
43	O
.	O
4	O
%	O
)	O
.	O

Histological	O
venous	B-Multi-tissue_structure
invasion	O
(	O
p	O
less	O
than	O
0	O
.	O
01	O
)	O
and	O
distant	O
metastasis	O
(	O
p	O
less	O
than	O
0	O
.	O
05	O
)	O
were	O
significantly	O
correlated	O
with	O
p53	O
protein	O
expression	O
.	O

The	O
two	O
parameters	O
were	O
more	O
frequently	O
observed	O
in	O
the	O
SCC	B-Cancer
with	O
VEGF	O
/	O
p53	O
coexpression	O
than	O
in	O
those	O
without	O
the	O
coexpression	O
.	O

The	O
MVD	O
and	O
Ki	O
-	O
67	O
LI	O
were	O
significantly	O
higher	O
(	O
p	O
less	O
than	O
0	O
.	O
01	O
and	O
p	O
less	O
than	O
0	O
.	O
001	O
)	O
,	O
and	O
the	O
AI	O
was	O
significantly	O
lower	O
(	O
p	O
less	O
than	O
0	O
.	O
001	O
)	O
in	O
the	O
SCC	B-Cancer
with	O
p53	O
protein	O
expression	O
than	O
in	O
the	O
SCC	B-Cancer
without	O
it	O
.	O

The	O
MVD	O
and	O
Ki	O
-	O
67	O
LI	O
were	O
higher	O
,	O
and	O
the	O
AI	O
was	O
lower	O
in	O
the	O
SCC	B-Cancer
with	O
VEGF	O
/	O
p53	O
coexpression	O
than	O
in	O
those	O
without	O
the	O
coexpression	O
.	O

The	O
5	O
-	O
yr	O
survival	O
rate	O
in	O
patients	O
with	O
the	O
coexpression	O
was	O
poorer	O
than	O
in	O
the	O
other	O
patients	O
.	O

CONCLUSION	O
:	O
These	O
results	O
suggest	O
that	O
mutant	O
p53	O
expression	O
is	O
associated	O
with	O
angiogenesis	O
and	O
distant	O
metastasis	O
in	O
esophageal	B-Cancer
SCC	I-Cancer
,	O
and	O
that	O
the	O
coexpression	O
of	O
p53	O
and	O
VEGF	O
may	O
play	O
an	O
important	O
role	O
in	O
angiogenesis	O
,	O
and	O
have	O
important	O
clinical	O
significance	O
.	O

